Chembio HIV test
This article was originally published in The Tan Sheet
Executive Summary
Chembio announces a new method for performing its HIV 1/2 STAT-PAK Dipstick test during the International AIDS Conference in Toronto, Canada. The new procedure involves placing the test strip on a flat laminate card like a "standard cassette test, yet without the cost and weight of cassette components," the company states in an Aug. 15 release. Customers can still use the original tube procedure as an alternate testing method. Chembio is moving closer toward OTC HIV tests since it filed a CLIA waiver application in July that allows the firm to market its tests to physician offices, clinics and other public health venues. HIV STAT-PAK Dipstick is not yet FDA-approved. Chembio received approval for its SURE CHECK HIV 1/2 and HIV 1/2 STAT-PAK tests in May 1("The Tan Sheet" June 5, 2006, p. 3)...
You may also be interested in...
Chembio HIV Tests Could Present OTC Competition For OraSure
Chembio Diagnostics intends to pursue OTC status for its SURE CHECK HIV 1/2 and HIV 1/2 STAT-PAK rapid tests, the company said upon announcing FDA approval of the two products May 30
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.